GBS Inc. – NASDAQ:GBS
GBS stock price today
$0.455
+0.17
+64.83%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
GBS stock price quarterly change
-29.61%
quarter
GBS stock price yearly change
-81.10%
year
GBS key metrics
Market Cap | 433.57K |
Enterprise value | N/A |
P/E | -0.94 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 39630.25 |
Price/Book | 1.33 |
PEG ratio | -0.10 |
EPS | -10.21 |
Revenue | 1.21M |
EBITDA | -13.12M |
Income | -14.03M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -2601457.79% |
Oper. margin | -4564870.55% |
Gross margin | 0% |
EBIT margin | -4564870.55% |
EBITDA margin | -1077.26% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGBS stock price history
GBS stock forecast
GBS financial statements
| Mar 2022 | 192.5K | -1.33M | -692.12% |
|---|---|---|---|
| Jun 2022 | 436.96K | -2.07M | -475% |
| Mar 2023 | 457.05K | -6.34M | -1387.99% |
| Jun 2023 | 131.81K | -4.28M | -3250.72% |
| 2022-02-10 | -0.16 | -0.23 |
|---|---|---|
| 2022-05-10 | -0.16 | -0.09 |
| 2022-08-31 | -0.18 | -0.14 |
| Sep 2022 | 10159703 | 4.96M | 48.86% |
|---|---|---|---|
| Dec 2022 | 18047933 | 7.78M | 43.13% |
| Mar 2023 | 10668701 | 4.74M | 44.45% |
| Jun 2023 | 10354612 | 6.66M | 64.39% |
| Mar 2022 | -1.63M | -177.20K | 1.38M |
|---|---|---|---|
| Jun 2022 | -1.72M | -703.01K | 0 |
| Mar 2023 | 0 | 0 | 0 |
| Jun 2023 | -4.65M | -219.25K | 1.43M |
GBS alternative data
| Aug 2023 | 12 |
|---|---|
| Sep 2023 | 12 |
| Oct 2023 | 12 |
| Nov 2023 | 12 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Apr 2024 | 12 |
| May 2024 | 12 |
| Jun 2024 | 12 |
| Jul 2024 | 12 |
GBS other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 63971 | 0 |
| Aug 2023 | 100 | 0 |
| Sep 2023 | 50 | 0 |
| Oct 2023 | 365451 | 0 |
| Quarter | Transcript |
|---|---|
| Q4 2022 1 Sep 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 14 May 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 10 Feb 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 11 Nov 2021 | Q1 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Harry Simeonidis (1968) Pres of Asia Pacific - Sales & Marketing | $302,600 |
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law (1962) Chief Financial Officer | $265,580 |
Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D. (1957) Interim Chief Executive Officer & Chairman | $20,510 |
-
What's the price of GBS stock today?
One share of GBS stock can currently be purchased for approximately $0.46.
-
When is GBS's next earnings date?
Unfortunately, GBS's (GBS) next earnings date is currently unknown.
-
Does GBS pay dividends?
No, GBS does not pay dividends.
-
How much money does GBS make?
GBS has a market capitalization of 433.57K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 187.52% to 1.26M US dollars. GBS made a loss 10.63M US dollars in net income (profit) last year or -$0.14 on an earnings per share basis.
-
What is GBS's stock symbol?
GBS Inc. is traded on the NASDAQ under the ticker symbol "GBS".
-
What is GBS's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of GBS?
Shares of GBS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are GBS's key executives?
GBS's management team includes the following people:
- Mr. Harry Simeonidis Pres of Asia Pacific - Sales & Marketing(age: 57, pay: $302,600)
- Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law Chief Financial Officer(age: 63, pay: $265,580)
- Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D. Interim Chief Executive Officer & Chairman(age: 68, pay: $20,510)
-
How many employees does GBS have?
As Jul 2024, GBS employs 12 workers.
-
When GBS went public?
GBS Inc. is publicly traded company for more then 4 years since IPO on 23 Dec 2020.
-
What is GBS's official website?
The official website for GBS is gbs.inc.
-
Where are GBS's headquarters?
GBS is headquartered at 708 3rd Avenue, New York, NY.
-
How can i contact GBS?
GBS's mailing address is 708 3rd Avenue, New York, NY and company can be reached via phone at +64 6 828 8258.
GBS company profile:
GBS Inc.
gbs.incExchange:
NASDAQ
Full time employees:
12
Industry:
Medical - Devices
Sector:
Healthcare
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
708 3rd Avenue
New York, NY 10019
New York, NY 10019
CIK: 0001725430
ISIN: US36151G1058
:
